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The prostaglandins appear to be rapidly formed 
and destroyed in a series of reactions beginning 
with esterified precursor fatty acids in the tissue 
and ending with various oxidized metabolit.es 
which appear in the urine. Concentrations of any of 
the intermediate prostaglandins at any locus are 
seldom very high and any event that diminishes the 
rate of formation or increases the rate of oxidation 
and/or removal of the prostaglandin is likely to 
diminish its effect. Little prostaglandin can be 
formed until esterified precursors are converted to 
nonesterified acids. The increased release of pros-
taglandin from cells upon agitation or during 
endocytic or exocytic events suggests that effects 
upon the cell membrane are expressed through 
acti\"ation of a carboxyest.erase and subsequent 
oxidative cyclization of the liberated acid to the 
active autacoid. 
Prevention of the stimulation of hydrolase activ-
ity may be achieved by stabilizing lysosomal 
mem branes, inhibiting the carboxyesterase(s), or 
by increasing intracellular cyclic adenosine mono-
phosphate (cAMP) levels. In light of the range of 
agents that can promote any of these events, it is 
not surprising that the substrate fatty acid availa-
bility may be reduced by a wide variety of com-
pounds. such as: local anaesthetics that interfere 
with phospholipase action: hydrophobic anti-
malarials or steroids that may "stabilize"' mem-
branes; chela tors that remove Ca 2- needed by 
acylhydrolases; and hormones or purines that ele-
vate the cytoplasmic cAMP concentration. 
The oxygenase converting the polyunsaturated 
fatty acid to active cyclic derivatives proceeds by a 
mechanism that shows positive feedback in being 
activated by its product and negative feedback in 
catalyzing its own destruction [1,2J. Three types of 
interaction of the enzyme appear t.o be involved in 
the reaction: that with substrate acid, oxygen, and 
an activator. 
Binding of substrate acids to the enzyme can be 
reversibly, competitively blocked by other fatty 
acids. with long-chain polyunsaturated acids 
having the greatest affinity. For example, 22:6 
(n - 3l has a K, ~ l.1 / 10- ' M . The ratio of 
precursor acids to inhibitory competitors in the 
tissue esters might influence the capacity of the 
released acids to form prostaglandins. Antioxi-
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dants are also reversible inhibitors [3] although the 
inhibition may be of competitive, noncompetitive, 
or mixed type. Suggestions that antioxidants may 
retard aging processes might reflect a blockade 01 
not only t issue damage in general, but also inhibi -
tion of prostaglandin formation and of in!1amma-
tory events that could contribute either to free 
radical damage or to subsequent autoimmune 
reactions associated with aging. 
P rogressive, irreversible loss of oxygena e activ-
ity in the presence of certain nonsteroidal anti-
inflammatory agents can be characterized by two 
steps: a reversible binding of the agent to the 
enzyme, followed by a fi rst order decay of the EI 
complex to inactive enzyme. 
E + I ~IEl A E" 
and In!lE, - E'l /Ed ~ - lk /K ,[lD·[/ j ./ 
Indomethacin and aspirin bind to the same locus on 
the enz\,me that subst rate does and their action can 
be pre;ented in part by substrate. Wh en added to 
the enzyme alone. they give appreciably rapid loss 
of acti"itv at concemrations below their K , value 
so that the val ue of the apparent decay constan t. 
k [I ]/K , - [IJ. i proportional to [I J. Acet~'lenic an-
alogs of fatt~' acids that cause ti me-dependent in-
activation act more slowl~' and their action a t con-
centrations abo\'e their K , value has been reported 
[4 ]. 
Accelerative, positi\"e feedbac k from an ac ti"at -
ing product is manifested in (allags at initial stages 
of the reaction. (b) greater \"elocities in reaction 
mixt.ures that contain preformed products. and (c) 
inhibi tion of the OX~'genase by a functioning gluta. 
thione peroxidase system . The latter t~'pe of en-
zyme may act phys iologically to suppress act i"a-
tion. and therefore function. of the oxygenase. 
Thus. there may be th ree physiologic aspects oj 
inhibition of prostaglandin synthesis: self-cata-
lyzed destruction (repaired by new protein synthe-
;is); inhibition by competitive fatty acid analogs: 
inhibition due to glutathione peroxidase remO\'al 
of an essential activator. 
Agents. or drugs. that bind at t.he acti,'ato r site 
tend to increase the lag phase as more activawr 
must be produced w reach optimal activity. The 
kinetic pattern of inhibition by such agents mark· 
edly differs from the linear pattern normally seen 
with agents competitive at the substrate site. 
Acetamidophenol appears to inhibit. reve rsibly at 
the activator site whereas non precursor fatty acids 
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act reversibly at the substrate site and indomeLha-
cin and aspirin act irreversibly a t the subst rate ite. 
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